SecBot SecBot

EMN

EASTMAN CHEMICAL CO
NYSE· Plastic Materials, Synth Resins & Nonvulcan Elastomers· Inc. DE· CIK 0000915389 Materials & Mining
$63.49 −1.54 (−2.37%)
Nov 16 4:00 PM ET · prev $65.03
Market cap
$7.5B
Mid cap
Consensus
Buy
48% Buy or better · 23 analysts
Median target
$76.00
+20% · range $65.00–84.00
1 year
+10.4%
from $57.49 · Nov 17
30 days
+1.6%
from $62.48
52-week range
$56.37–81.36
−22% from high · low Nov 20
Avg volume 20D
1.35M
shares / day
Short interest
5.54M
≈4.8% of shares · −11.4%
Days to cover
3.5
at average volume
Insider net
−$205.8K
1 buyer · 1 seller · since Feb 24
New fund stakes
2
Q3 2026 13F · 3 exits
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 1 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 4/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $160.0K at an average $65.28. 1 insider sold $365.8K.

  • InstitutionsBULLISH

    Q3 2026: 49 added (2 new), 24 trimmed or exited. Largest new: Squarepoint Ops $28.4M, Qube Research & Technologies $11.6M.

  • AnalystsBULLISH

    11 of 23 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −11.4% to 5.54M shares. 3.5 days to cover, ≈4.8% of shares.

  • TrendRANGE

    3% below its 50-day average.

Who's buying

13F· Q3 2026
2
new positions
3
exits
$40.0M
in new stakes
FundMoveSharesValue
Boston PartnersADD2,795,537$181.2M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD1,429,341$92.7M
UBS Group AGADD1,255,472$81.4M
Quantinno Capital Management LPDOUBLED799,289$51.8M
MACKENZIE FINANCIAL CORPDOUBLED757,514$49.1M
PUBLIC SECTOR PENSION INVESTMENT BOARDADD717,021$44.8M
RENAISSANCE TECHNOLOGIES LLCDOUBLED544,940$35.3M
Squarepoint Ops LLCNEW438,071$28.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

23 analysts
Buy 48% rate it Buy or better
Strong Buy6Buy5Hold12Sell0Strong Sell0
12-month targets · 16 analysts

Price is below the lowest target. Median implies +20%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 4, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Nov 3, 2026Citigroup
MAINTAIN
MAINTAINBuy
Nov 2, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Nov 2, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 16, 2026JP Morgan
DOWNGRADE
DOWNGRADENeutral
Oct 13, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform

Insider ledger

Form 4
$160.0K
bought · 1 insider
$365.8K
sold · 1 insider
−2.7%
vs their $65.28 cost
DateInsiderTypeValue
Nov 6, 2026
McAlindon Julie A.
SVP, Regions & Chf SupChn Ofcr
Nov 6, 2026
BUY$160.0K
Oct 7, 2026
OBRIEN JAMES J /KY
Director
Oct 7, 2026
AWARD480 sh
Oct 7, 2026
SLAGER DONALD W
Director
Oct 7, 2026
AWARD480 sh
Oct 7, 2026
Mink Kim Ann
Director
Oct 7, 2026
AWARD480 sh
Oct 7, 2026
BEGEMANN BRETT D
Director
Oct 7, 2026
AWARD480 sh
Oct 7, 2026
Alfonso Humberto P
Director
Oct 7, 2026
AWARD$73.5K
Oct 7, 2026
Alfonso Humberto P
Director
Oct 7, 2026
AWARD480 sh
Oct 7, 2026
BEGEMANN BRETT D
Director
Oct 7, 2026
AWARD$86.1K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

57 lobbying filings and 1 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
5,540,811
shares short
-11.4%
vs prior settlement
3.5
days to cover
≈4.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Eastman Chemical issued $300 million of 5.500% senior unsecured notes due 2030, completing a debt capital raise that…
8-K · Impact 3/10
Nov 6, 2026 Insider
McAlindon Julie A. bought 2,451 shares
SVP, Regions & Chf SupChn Ofcr @ $65.28 ($160.0K)
Nov 3, 2026 SEC
Eastman Chemical issued $300 million of 5.500% senior unsecured notes due 2030 in an underwritten takedown from its…
424B5 · Impact 3/10
Nov 2, 2026 SEC
Eastman Chemical filed a preliminary prospectus supplement for an underwritten public offering of senior unsecured…
424B5 · Impact 3/10
Oct 29, 2026 Earnings result
EMN Q3 2026 Earnings: EPS $1.84 (-5.1% vs est)
Oct 7, 2026 Insider
OBRIEN JAMES J /KY was granted 480 shares
Director
Oct 7, 2026 Insider
SLAGER DONALD W was granted 480 shares
Director
Sep 30, 2026 Inst.
Boston Partners · ADD
2,795,537 shares ($181.2M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 29, 2026
Earnings result
EMN Q3 2026 Earnings: EPS $1.84 (-5.1% vs est)
Jul 30, 2026
Earnings date
EMN Q2 2026 Earnings After Market Close, 2026-07-30
Apr 30, 2026
Earnings date
EMN Q1 2026 Earnings After Market Close, 2026-04-30
Apr 6, 2026
Short interest
FTD: EMN, 48,149 shares ($3.6M) failed to deliver
Settlement: 20260406, Price: $75.07, FTD Value: $3,614,545.43, EASTMAN CHEMICAL CO
Mar 26, 2026
Short interest
FTD: EMN, 44,388 shares ($3.2M) failed to deliver
Settlement: 20260326, Price: $71.40, FTD Value: $3,169,303.2, EASTMAN CHEMICAL CO

SecBot reports

7 filings · 0 bullish · 1 bearish · 6 neutral
All EMN filing & press-release reports (7)